Drug Safety and Pharmacovigilance Across the Product Lifecycle

Build a solid foundation in the key concepts of drug safety and pharmacovigilance throughout the medical product development lifecycle. Learn how to comply with regulatory requirements.

返回 Agenda

Session 11: Post-Marketing Safety Principles and Spontaneous Case Reporting

Session Chair(s)

Jill W. Buckley, PharmD

Adjunct Assistant Professor

Rutgers, the State University of New Jersey, United States

This session provides an overview of the principles of safety reporting associated with marketed medicinal products including spontaneous reporting systems.

Drug Safety and Pharmacovigilance Across the Product Lifecycle

Session 11: Post-Marketing Safety Principles and Spontaneous Case Reporting

Session Chair(s)

Jill W. Buckley, PharmD

获得信息并保持参与